Deciphera Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DECIPHERA PHARMS, and when can generic versions of DECIPHERA PHARMS drugs launch?
DECIPHERA PHARMS has one approved drug.
There are fifteen US patents protecting DECIPHERA PHARMS drugs.
There are sixty-eight patent family members on DECIPHERA PHARMS drugs in thirteen countries.
Summary for Deciphera Pharms
International Patents: | 68 |
US Patents: | 15 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Deciphera Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,266,635 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,395,818 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,426,390 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,612,591 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,576,904 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,185,535 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,529,336 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Deciphera Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 3163051 | ⤷ Try a Trial |
China | 114303195 | ⤷ Try a Trial |
South Korea | 20110074633 | ⤷ Try a Trial |
Eurasian Patent Organization | 200970280 | ⤷ Try a Trial |
Israel | 293864 | ⤷ Try a Trial |
Mexico | 2009002813 | ⤷ Try a Trial |
Japan | 2023509628 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.